Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 15 studies | 29% ± 12% | |
peripheral blood | 15 studies | 32% ± 9% | |
intestine | 6 studies | 20% ± 3% | |
kidney | 4 studies | 31% ± 14% | |
lymph node | 4 studies | 46% ± 20% | |
bone marrow | 3 studies | 23% ± 6% | |
liver | 3 studies | 29% ± 13% | |
prostate | 3 studies | 28% ± 5% | |
brain | 3 studies | 29% ± 9% | |
skin | 3 studies | 21% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 7941.48 | 1445 / 1445 | 100% | 176.77 | 183 / 183 |
prostate | 100% | 10430.56 | 245 / 245 | 100% | 459.44 | 501 / 502 |
pancreas | 100% | 7636.29 | 328 / 328 | 99% | 229.19 | 177 / 178 |
lung | 100% | 12017.52 | 578 / 578 | 99% | 266.99 | 1147 / 1155 |
stomach | 100% | 7750.13 | 359 / 359 | 99% | 246.80 | 284 / 286 |
thymus | 100% | 5635.14 | 652 / 653 | 99% | 139.66 | 600 / 605 |
intestine | 99% | 6704.74 | 961 / 966 | 99% | 302.12 | 524 / 527 |
bladder | 100% | 4548.14 | 21 / 21 | 99% | 256.25 | 498 / 504 |
ovary | 99% | 3207.31 | 178 / 180 | 100% | 217.70 | 429 / 430 |
breast | 100% | 7754.78 | 459 / 459 | 98% | 253.06 | 1101 / 1118 |
uterus | 100% | 4449.14 | 170 / 170 | 97% | 183.82 | 444 / 459 |
kidney | 100% | 6756.35 | 89 / 89 | 95% | 144.44 | 853 / 901 |
liver | 100% | 3830.89 | 225 / 226 | 93% | 104.26 | 378 / 406 |
adrenal gland | 100% | 4115.19 | 258 / 258 | 69% | 45.95 | 159 / 230 |
skin | 75% | 7610.57 | 1355 / 1809 | 86% | 78.27 | 406 / 472 |
brain | 83% | 2600.01 | 2190 / 2642 | 51% | 39.41 | 363 / 705 |
adipose | 100% | 6180.10 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 410.60 | 29 / 29 |
muscle | 100% | 13951.08 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 10931.83 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 246.23 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 233.42 | 1 / 1 |
blood vessel | 100% | 6551.16 | 1333 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 14526.00 | 921 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 5578.81 | 843 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 54% | 29.23 | 43 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045055 | Biological process | regulated exocytosis |
GO_0048499 | Biological process | synaptic vesicle membrane organization |
GO_0030672 | Cellular component | synaptic vesicle membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005811 | Cellular component | lipid droplet |
GO_0031594 | Cellular component | neuromuscular junction |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | SYNGR2 |
Protein name | Synaptogyrin 2 Synaptogyrin-2 (Cellugyrin) |
Synonyms | UNQ352/PRO615 hCG_27833 |
Description | FUNCTION: May play a role in regulated exocytosis. In neuronal cells, modulates the localization of synaptophysin/SYP into synaptic-like microvesicles and may therefore play a role in the formation and/or the maturation of this vesicles. May also play a role in GLUT4 storage and transport to the plasma membrane. .; FUNCTION: (Microbial infection) May play a role in the assembly of cytoplasmic inclusion bodies required for SFTS phlebovirus replication. . |
Accessions | K7ENG9 ENST00000588282.5 [O43760-2] K7ELS8 ENST00000589183.1 ENST00000590201.1 ENST00000589711.1 K7ELD9 ENST00000589168.1 O43760 ENST00000585591.5 [O43760-1] ENST00000225777.8 [O43760-1] K7EJ35 |